MiRXES

About MiRXES

MiRXES is a biotechnology company focused on early cancer detection and precision oncology through RNA-based diagnostics. The company offers cancer screening solutions (e.g., GASTROClear and LUNGClear) and tissue/genomics profiling (APEX Tissue, COMPASS Tissue, Discovery Genomics, and ID3EAL Suite) to enable earlier intervention and personalized treatment decisions. Headquartered in Singapore as MiRXES Pte Ltd, it operates globally, combining proprietary miRNA and RNA technologies with biobanking and genomics services to support clinicians and researchers in cancer care. The company emphasizes advancing disease interception and reducing late-stage diagnoses through minimally invasive tests and sequencing-based insights.